Investor relations
ALS is the global benchmark for quality and integrity in the scientific testing and analysis sector. We have built our reputation on client service, innovation, quality and technical excellence. With corporate headquarters in Brisbane, Australia, and Global Operations in Houston, Texas, USA, we are an ASX100 company with a multi-billion-dollar market capitalisation.
ALS operates one of the world’s largest analytical and testing services businesses with more than 350 sites in over 65 countries across the globe. We are focused on driving growth by continuing to successfully operate our existing businesses through innovation and the pursuit of new opportunities.
01 JUN 2023
DOWNLOAD29 MAY 2023
DOWNLOAD29 MAY 2023
DOWNLOAD29 MAY 2023
DOWNLOAD29 MAY 2023
DOWNLOAD31 MAR 2023
29 MAY 2023
26 JUL 2023
30 SEP 2023
14 NOV 2023
B Sc (Hons) (Geology)
Chairman and Independent Non-Executive Director
Bruce Phillips was appointed a Non-Executive Director of the Company on 1 August 2015 and became Chairman on 26 July 2016 following the 2016 Annual General Meeting. Bruce is a qualified geophysicist with more than 35 years of technical, financial and managerial experience in the energy sector.
Master of Laws, Juris Doctor
Chief Executive Officer and Managing Director
Newly appointed as CEO and Managing Director for ALS Limited, Malcolm Deane has served the company in various executive positions for the past 10 years in such roles as GM for Life Sciences Latin America, Food & Pharma Americas, and most recently as the Chief Strategy Officer, leading corporate strategy, business development and acquisitions. Malcolm has a Master of Laws from the University of Virginia School of Law and Juris Doctor from Universidad Austral – Buenos Aires, Argentina.
PhD, B E (Civil Eng) (Hons), FIE Aust
Independent Non-Executive Director
John Mulcahy was appointed a Non-Executive Director of the Company in 2012. He is Chairman of Mirvac Group Limited (appointed November 2009 and Chair September 2013) and Orix Australia Corporation Limited, an unlisted public company (appointed March 2016), and Deputy Chairman of GWA Group Limited (appointed November 2010). He is also a current Non-Executive Director of various Zurich Australia Insurance subsidiaries.
B ENG (Hons) (Mining), FAusIMM, FTSE
Independent Non-Executive Director
Charlie Sartain was appointed a Non-Executive Director of the Company on 1 February 2015. He spent more than 30 years with MIM Holdings and then Xstrata plc after it acquired MIM. He led Xstrata’s global copper business as Chief Executive of Xstrata Copper for nine years from 2004 and prior to that held senior executive positions with the company in Latin America and Australia.
B Juris (Hons), LLB (Hons), GAICD
Independent Non-Executive Director
Tonianne Dwyer was appointed a Non-Executive Director of the Company on 1 July 2016. She has significant experience as a company director and executive working in finance, corporate strategy and mergers and acquisitions across a variety of sectors and international markets.
Ph.D. Biomedical Engineering, B.E., Electronics and Telecommunication
Independent Non-Executive Director
Siddhartha Kadia was appointed a Non-Executive Director of the Company in January 2019. Siddhartha was formerly President and CEO of EAG Laboratories, a global scientific testing company headquartered in San Diego. He has a PhD in Biomedical Engineering from Johns Hopkins School of Medicine. Siddhartha has lived and worked in the US, Japan, China and India and has more than 20 years of international experience as a company director, executive and technical leader in the Life Sciences and TIC (testing, inspection and certification) sectors.
B. Industrial Admin, Finance (Kettering), MS. Management (MIT)
Independent Non-Executive Director
Leslie Desjardins was appointed a Non-Executive Director of the Company on 21 November 2019. She has a background as a CFO and senior financial and governance professional in a range of large multinational and global businesses. Ms Desjardins is currently a Director, Audit Committee Chair, CSR/Risk Committee member with Ansell Limited and Director and Audit Committee Chair with Terry Fox Foundation, Canada.
B ASc., Chemistry/Microbiology, University of South Australia
Independent Non-Executive Director
Peter Possemiers has been named independent Non-Executive Director, effective November 1st, 2022. A 40-year veteran of the TIC sector, he held multiple executive leadership roles for SGS, most notably in global Environment Health and Safety, a CHF $550 million business. As Executive Vice President there, he was a member of their Operations Council with responsibility for growth and profitability, steering 15 strategic acquisitions. Mr. Possemiers is a respected leader with a deep understanding of TIC practices across multiple regions. His M&A track record and network relationships will provide invaluable insight and benefits for ALS Limited.
Dividend paid per share (cents) is 42.0% up to 32.8 cents per share
Revenue for financial year 2022 was $2.182 billion (AUD)
Net profit after tax was $264.2 million (AUD)
Statutory earnings per share for financial year 2022 was 39.5 cents per share (CPS)
Being a global leader means assembling the right teams. We pride ourselves in recruiting top talent and offering a safe, inclusive, educational environment with the necessary resources to inspire continued growth.
Environmental responsibility is a priority. Throughout our field work, we regularly seek opportunities to minimize our impact by conserving resources, reducing waste and more using more sustainable material.
ALS offers testing and inspection services that help people all over the world. Through these efforts, we contribute to communities by creating shared value with our local partners. This includes providing employment opportunities and partnering with local contractors and suppliers.
We hold ourselves to high standards of professional integrity. Regulatory frameworks promoting transparency and accountability allow us to build a trusting relationship with our stakeholders.
A list of key contact people within ALS Limited who are available to help you with various Investor related queries. For more information please contact:
enquiries@boardroomlimited.com.au www.boardroomlimited.com.au
PO Box 66
Everton Park, Queensland
Australia 4053
T: +61 (0)7 3367 7900
F: +61 (0)7 3367 8156
Share Registry
PO Box 3993
Sydney, NSW
2001 Australia
T: 1300 737 760
F: +61 (0)2 9279 0664
Level 14, 385 Bourke Street
Melbourne VIC
3000 Australia
M: +61 412 430 393
GENERAL INFORMATION